You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》美因基因(06667.HK)公開發售超購8.6倍及下限18元定價 一手中籤率僅10%
阿思達克 06-21 08:41
美因基因(06667.HK)公布招股結果,每股發售價定為18元,為招股價範圍(18至22元)的下限定價,香港公開發售部分錄得超額認購約8.62倍。每手200股計,一手中籤率10.01%,要認購20手即4,000股才穩獲一手。該股將於明日(22日)掛牌。獨家保薦人為中信建投國際。 基石投資者南昌金融、南昌工控園區及邁克生物合共認購公司969.28萬股,佔緊隨全球發售完成後公司已發行股本約4.05%。 公司是次上市料淨集資約1.53億元,擬將約30%用於消費級基因檢測及癌症篩查服務及產品的銷售、營銷及商業化;約25%投資於研發我們的服務及產品;約20%用於增加或擴大檢測能力及產能;約15%用於通過投資或收購與公司現有業務互補及協同的具吸引力的技術或檢測相關公司;約10%用作營運資金及其他一般企業用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account